Interpace Biosciences Announces Early Repayment of Debt to BroadOak Capital Partners
PARSIPPANY, NJ, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCID: IDXG) (“Interpace” or the “Company”) today…
1,058$
9,53%
Echtzeit-Aktienkurs INTERPACE BIOSCIEN.DL-,01
Bid:
Ask:
Nachrichten zur INTERPACE BIOSCIEN.DL-,01 Aktie
Effective 02/07/2025, Interpace Diagnostics® to No Longer Offer PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk
PARSIPPANY, NJ, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, (“Interpace” or the…